Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Samenvatting

Samenvatting Mechanisms of Disease 2

Beoordeling
-
Verkocht
-
Pagina's
144
Geüpload op
24-07-2023
Geschreven in
2021/2022

Volledige samenvatting van het vak Mechanisms of Disease 2 (MOD2) van jaar 2 Geneeskunde Leiden. Aantekeningen van alle hoorcolleges. Vak gehaald mbv deze samenvatting alleen.

Instelling
Vak

Voorbeeld van de inhoud

Samenvatting MOD2

HC2 Cancer biology: the hallmarks of cancer

- From healthy to malignant
o Healthy cells / tissues are highly organised (in number and function)
▪ A/B/C – healthy
▪ D/E/F/G – malignant




- Hallmarks of cancer
o Sustaining proliferative signalling
o Evading growth suppressors
o Avoiding immune destruction
o Enabling replicative immortality
o Tumor-promoting inflammation
o Activating invasion & metastasis
o Inducing angiogenesis
o Genome instability & mutation
o Resisting cell death
o Deregulating cellular energetics
- 1. Sustaining proliferative signalling
o Cell proliferation pathway (MAPK
pathway) → this pathway connects receptors
at cell surface to the nucleus where
transcription of genes happens
o Healthy cell: this pathway will not be
activated unless it receives a stimulus from
outside (growth factors) → the availability of
these growth factors is very limited
o Tumor cells: sequester / detach
these signalling pathways with the goal of becoming completely independent (=
sustaining proliferative signalling)
o This detaching of the signalling pathway can be done at different levels of the
pathway:
▪ Overexpression of growth factors (EGF, VEGF)→ tumor cells will start
expressing these growth factors in large numbers
▪ Overexpression of cell surface receptors and/or activating mutations EGFR,
HER2) → by maximising the number of receptors, you can bind all the
potential ligands around the cell + activating mutations that, for example,
activate proteins (e.g. mutation that causes receptors to be constantly



1

, active, and thus constantly activate the signalling pathway, without needing
growth factor as a stimulus)
▪ Overexpression of intracellular signalling molecules or activating mutations
(KRAS, BRAF) → same mechanism as above, but then intracellular →
mutations that cause proteins to be constantly active & constantly
phosphorylate subsequent proteins & activate transcription of target genes,
without the need of signals from above (thus leads to independence of
extracellular signals)
▪ Overexpression of transcription factors (MYC, beta-catenin) → by doing this,
a tumor cell becomes completely independent from a signalling cascade
▪ All above named genes promote tumor development once they are
overexpressed or mutated → genes that can stimulate cancer development
are referred to as proto-oncogenes (let op!! Proto-oncogenes are genes
involved in normal cell growth!! Only when mutations in proto-oncogenes
occur, it may become an oncogene which causes the growth of cancer cells)
- 2. Evading growth suppressors
o Healthy cells have a number of mechanisms that are supposed to control
exaggerated cell division
o In healthy cells, the expression of growth suppressor genes is much higher than the
expression of growth promotor genes
o In tumour cells, this balance has shifted → much more expression of growth
promotor cells than expression of growth suppressor cells




o Cell-cycle checkpoints
▪ Important mechanism to keeping cells in check
▪ Start checkpoint: checkpoint between G1 phase and S phase (S phase = DNA
replication) → restriction point in which the cell checks if everything is okay
& if something is wrong with the cell, this checkpoint will stop it from
undergoing DNA replication
▪ G2/M checkpoint: checkpoint between G2 and M phase (mitosis) → to check
if everything is okay before the cell starts dividing
▪ All these checkpoints are major growth suppressors → they stop ‘faulty’ cells
from growing
o Tumour growth
▪ In tumour growth we often see loss-of-function mutations of growth
inhibitors (TGFβ receptor, p16) → tumour suppressor genes
▪ Tumour suppressor genes are normal genes that slow down cell division,
repair DNA mistakes or induce apoptosis (of faulty cells). It is only when loss-
of function mutations occur in these genes → that cells can grow out of
control & lead to cancer



2

, o Thus:
▪ Loss of function mutation of growth inhibitors (= tumour suppressors) (TGFβ
receptor, p16)
▪ Gain of function mutations of growth factors (= proto-oncogene) → once
mutation occurs: oncogenes (Cyclin D, CDK4)
o TP53 – the main tumor suppressor gene
▪ TP53 reacts to a variety of extracellular stimuli: hyperproliferative signals,
DNA damage, telomere shortening, hypoxia → all these stimuli activate TP53
▪ TP53 is mutated in > 50% of all human tumors (TP53 = guardian of the
genome)
▪ P53-related pathways affected in > 90% of all tumours
▪ Loss of p53 → loss of cell cycle checkpoints → proliferation of cells with DNA
damage
▪ Some people have a hereditary (heterozygous) mutation in TP53 gene: Li
Fraumeni syndrome → these patients develop multiple primary tumors of
various kinds at a young age. Dominant inheritance
o Wnt signalling pathway
▪ Two main proteins in Wnt signalling pathways:
• APC → tumour suppressor
• β – catenin → oncogene
▪ Healthy cell: APC binds to beta-catenin and destroys it & thus prevents beta-
catenin from entering the nucleus & starting transcription of genes
▪ Tumour cell: tumour cell could have multiple mutations that can lead to
uncontrollable cell growth → most important ones: loss-of-function
mutation in tumour suppressor gene APC or gain of function mutation in
oncogene β – catenin gene.
▪ APC is a main tumour suppressor in colorectal cancer




- 3. Avoiding immune destruction
o Ex: mutation in HLA/MHC class I expression → if tumour cells do not have an MHC
class I molecule, they cannot present any peptides & thus cannot be recognized by T
cells
- 4. Enabling replicative immortality
o Normal cells have limited proliferative capacity
o Once cells have divided a certain number of times → they enter a state of
(replicative) senescence (= aging)



3

, ▪ → meaning they have lost the ability to re-enter the cell cycle & generate
daughter cells
o Number of doublings dependent on species, tissue and age of organism →
embryonic stem cells can keep on dividing, but for ex. Adult stem cells and somatic
cells have limited proliferative capacity → somatic cells even worse than adult stem
cells (see graph)
o Human telomeres
▪ Contain 5-15kb of TTAGGG repeats → these repetitive sequences are there
to protect the actual part of the chromosome that is encoding genes and
thus important for cell survival
▪ Telomerase required for their replication
▪ Somatic cells do not express telomerase → thus telomeres shorten over time
→ until it gets to a point where the part of the chromosome that is actually
encoding genes necessary for cell survival, is exposed and can get damaged
▪ So, when the telomeres become extremely short/not present → the cell
receives the instruction to stop dividing (stop cell division)




o Tumours
▪ Tumour cells activate the telomerase gene → so that they can keep their
telomeres long & this thus gives a sort of limitless replicative potential to
cancer cells (they’re not inhibited anymore by the shortening of their
telomeres)
▪ Thus: activation of the TERT (telomerase) is a mechanism by which cancer
stabilizes telomeres
- 5. Activation of invasion & metastasis
o Primary tumours are often not what eventually kills patients → the spreading of
cancer cells throughout the body does. And even in the onset of cancer, it needs
some properties through which tumour cells can invade adjacent tissues
o Mechanisms of cancer cells to invade tissues and spread throughout the body:
▪ Loosening up of tumour cell to tumour cell interactions (inactivation of E-
cadherin)
• In healthy tissues: cells are strictly arranged & communicate with
each other → they can detect if something is wrong with the cell
next to them
• In tumours: loosening of cells & cell interaction
▪ Degradation of extracellular matrix (ECM) (expression of proteolytic
enzymes)


4

Geschreven voor

Instelling
Studie
Vak

Documentinformatie

Geüpload op
24 juli 2023
Aantal pagina's
144
Geschreven in
2021/2022
Type
SAMENVATTING

Onderwerpen

$13.95
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
famkew Universiteit Leiden
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
17
Lid sinds
5 jaar
Aantal volgers
7
Documenten
17
Laatst verkocht
10 maanden geleden

5.0

1 beoordelingen

5
1
4
0
3
0
2
0
1
0

Populaire documenten

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Veelgestelde vragen